Michael Hertl

15.9k total citations
239 papers, 7.7k citations indexed

About

Michael Hertl is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Michael Hertl has authored 239 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Pathology and Forensic Medicine, 135 papers in Rheumatology and 109 papers in Genetics. Recurrent topics in Michael Hertl's work include Autoimmune Bullous Skin Diseases (176 papers), Urticaria and Related Conditions (122 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (109 papers). Michael Hertl is often cited by papers focused on Autoimmune Bullous Skin Diseases (176 papers), Urticaria and Related Conditions (122 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (109 papers). Michael Hertl collaborates with scholars based in Germany, United States and Switzerland. Michael Hertl's co-authors include Rüdiger Eming, Gerold Schuler, Andrea Kneisel, Luca Borradori, Christian Veldman, Detlef Zillikens, Kyle T. Amber, Dario Didona, Thomas Schmidt and Roberto Maglie and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

In The Last Decade

Michael Hertl

233 papers receiving 7.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hertl Germany 52 5.6k 4.3k 3.9k 1.2k 876 239 7.7k
Luca Borradori Switzerland 45 4.2k 0.8× 3.2k 0.7× 3.1k 0.8× 832 0.7× 545 0.6× 209 6.8k
Enno Schmidt Germany 57 8.8k 1.6× 6.7k 1.6× 6.9k 1.8× 728 0.6× 706 0.8× 343 10.3k
Grant J. Anhalt United States 51 7.4k 1.3× 5.0k 1.2× 4.7k 1.2× 838 0.7× 1.9k 2.1× 170 11.0k
Kim B. Yancey United States 42 3.2k 0.6× 2.4k 0.6× 2.5k 0.7× 361 0.3× 925 1.1× 142 5.4k
A. Razzaque Ahmed United States 40 3.6k 0.6× 2.5k 0.6× 2.3k 0.6× 310 0.3× 488 0.6× 138 4.6k
Tadeusz P. Chorzelski United States 38 3.5k 0.6× 2.1k 0.5× 1.4k 0.4× 594 0.5× 499 0.6× 141 4.6k
Takeji Nishikawa Japan 33 2.6k 0.5× 2.1k 0.5× 1.8k 0.5× 495 0.4× 353 0.4× 164 4.5k
Fenella Wojnarowska United Kingdom 43 2.1k 0.4× 3.1k 0.7× 1.2k 0.3× 876 0.8× 255 0.3× 139 5.4k
Robert E. Jordon United States 36 2.8k 0.5× 2.0k 0.5× 1.3k 0.3× 463 0.4× 584 0.7× 83 3.9k
Thomas Hunziker Switzerland 30 1.4k 0.3× 1.3k 0.3× 813 0.2× 954 0.8× 585 0.7× 105 4.1k

Countries citing papers authored by Michael Hertl

Since Specialization
Citations

This map shows the geographic impact of Michael Hertl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hertl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hertl more than expected).

Fields of papers citing papers by Michael Hertl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hertl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hertl. The network helps show where Michael Hertl may publish in the future.

Co-authorship network of co-authors of Michael Hertl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hertl. A scholar is included among the top collaborators of Michael Hertl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hertl. Michael Hertl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stephan, Brigitte, Stephan Jeff Rustenbach, Matthias Augustin, et al.. (2024). Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest. Journal of Clinical Medicine. 13(13). 3713–3713. 1 indexed citations
2.
Hertl, Michael, et al.. (2023). Autoimmune skin disorders and SARS‐CoV‐2 vaccination – a meta‐analysis. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(8). 853–861. 9 indexed citations
3.
Schmitt, Thomas, et al.. (2023). Dsg3 epitope-specific signalling in pemphigus. Frontiers in Immunology. 14. 1163066–1163066. 15 indexed citations
4.
Plewig, Gerd, Lars E. French, Thomas Ruzicka, Roland Kaufmann, & Michael Hertl. (2022). Braun-Falco´s Dermatology. 8 indexed citations
5.
Hudemann, Christoph, Niklas Gremke, Wolfgang Pfützner, et al.. (2022). Isolation of Lymphocytes from Human Skin and Murine Tissues: A Rapid and Epitope-Preserving Approach. SHILAP Revista de lepidopterología. 3(1). 100155–100155. 3 indexed citations
6.
Hudemann, Christoph, Robert Pollmann, Anna Zakrzewicz, et al.. (2022). IgG against the Membrane-Proximal Portion of the Desmoglein 3 Ectodomain Induces Loss of Keratinocyte Adhesion, a Hallmark in Pemphigus Vulgaris. Journal of Investigative Dermatology. 143(2). 254–263.e3. 8 indexed citations
7.
Maho‐Vaillant, Maud, Corine Pérals, Marie-Laure Golinski, et al.. (2021). Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus. Journal of Investigative Dermatology. 141(9). 2132–2140.e1. 18 indexed citations
8.
Didona, Dario, Luca Fania, Biagio Didona, et al.. (2020). Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. International Journal of Molecular Sciences. 21(6). 2178–2178. 42 indexed citations
9.
Hudemann, Christoph, Robert Pollmann, Michael Hertl, Sarah Fleischer, & Rüdiger Eming. (2019). 031 Development of a mouse model of Pemphigus Vulgaris as a tool to evaluate nanoparticle induced antigen-specific tolerance. Journal of Investigative Dermatology. 139(9). S220–S220. 1 indexed citations
10.
Walter, Elias, Franziska Vielmuth, Lukas T. Rotkopf, et al.. (2017). Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Scientific Reports. 7(1). 3579–3579. 54 indexed citations
11.
Prost‐Squarcioni, C., F. Caux, Enno Schmidt, et al.. (2017). International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. British Journal of Dermatology. 179(1). 30–41. 45 indexed citations
12.
Enk, Alexander, Eva Hadaschik, Rüdiger Eming, et al.. (2016). European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology. Journal of the European Academy of Dermatology and Venereology. 30(10). 1657–1669. 41 indexed citations
13.
Hertl, Michael. (2011). Autoimmune diseases of the skin : pathogenesis, diagnosis, management. DIAL (Catholic University of Leuven). 12 indexed citations
14.
Möbs, Christian, et al.. (2010). Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation. The Journal of Immunology. 184(4). 2194–2203. 101 indexed citations
15.
Thoma-Uszynski, Sybille, et al.. (2006). Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230. The Journal of Immunology. 176(3). 2015–2023. 90 indexed citations
16.
Veldman, Christian, Andreas Pahl, Stefan Beissert, et al.. (2006). Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells. The Journal of Immunology. 176(5). 3215–3222. 58 indexed citations
17.
Veldman, Christian, Wolfgang Uter, Ralf Waßmuth, et al.. (2004). T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals. The Journal of Immunology. 172(6). 3883–3892. 93 indexed citations
18.
Veldman, Christian, et al.. (2004). Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris. The Journal of Immunology. 172(10). 6468–6475. 128 indexed citations
19.
Jacobi, Arnd, Gerold Schuler, & Michael Hertl. (2004). Long-term efficacy and safety of TNF-alpha-inhibitor infliximab in severe atopic dermatitis. Journal of the American Academy of Dermatology. 50(3). P3–P3. 3 indexed citations
20.
Hertl, Michael, et al.. (1969). Leukämie bei Kindern. Thieme eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Borradori Breakdown of academic impact, for papers by Enno Schmidt Breakdown of academic impact, for papers by Grant J. Anhalt Breakdown of academic impact, for papers by Kim B. Yancey Breakdown of academic impact, for papers by A. Razzaque Ahmed Breakdown of academic impact, for papers by Tadeusz P. Chorzelski Breakdown of academic impact, for papers by Takeji Nishikawa Breakdown of academic impact, for papers by Fenella Wojnarowska Breakdown of academic impact, for papers by Robert E. Jordon Breakdown of academic impact, for papers by Thomas Hunziker
Rankless by CCL
2026